Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

6 Stocks To Watch: AXSM, CFMS, CGC, CRSP, SWAV, VCYT

Published 05/07/2019, 12:55 AM
Updated 07/09/2023, 06:31 AM

Axsome Therapeutics, Inc. (AXSM)

AXSM a standout performance among biotech’s, broke out of a little five-day flag, popping 1.20, or 6.69%, to 19.15, on 3.2 million shares on Monday. I think it’s headed to 23.

Conformis, Inc. (CFMS)

CFMS which we put a swing on, is looking really good. I like the wedge breakout that occurred on Monday. It gained 16 cents, or 6.02%, to 2.82, on 4.7 million shares. At this rate, it looks to me like a rising channel may be tested in the 6-range, but let it get through the mid-range at about 4. So, 4 and 6 are targets going forward.

Canopy Growth Corporation (CGC)

CGC may have woken up on Monday. You can see that it came down and reversed, advancing only 12 cents to 49.20, but 3.5 million shares. It opened at 47.36 and closed at 49.20 at the upper end of the range. If this continues forward, it’s going to break out and run into the high 50’s, low 60’s.

CRISPR Therapeutics AG (CRSP)

CRSP has a beautiful inverse, head-and-shoulder platform right at the neckline, on Monday jumping 1.52, or 3.75%, to 42.09, on 586,684 shares traded. If it can get above 43, then 47, 53, and 59 are targets. This should be a swing.

ShockWave Medical, Inc. (SWAV)

SWAV continues to run and made new, IPO highs on Monday, spiking up 2.97, or 6.84%, to 46.40, on 500,682 shares traded. Targets going forward on this one are 50 and 54.

Veracyte, Inc. (VCYT)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

VCYT looks like it had an engulfing day on Monday, or at least some sort of positive reversal day, popping 90 cents, or 3.66%, to 25.50, on 1.75 million shares. All it has to do is get through 25.50 level. That’s going to be tough. Targets are 26.75, and then 31.00.

Stocks on the long side

Athenex, Inc. (ATNX), Avid Technology, Inc. (AVID), Axsome Therapeutics, Inc. (AXSM), Conformis, Inc. (CFMS), Canopy Growth Corporation (CGC), CRISPR Therapeutics AG (CRSP), Digimarc Corporation (DMRC), Esperion Therapeutics, Inc. (ESPR), GW Pharmaceuticals plc (GWPH), Idera Pharmaceuticals, Inc. (IDRA), ImmunoGen, Inc. (IMGN), Intelligent Systems Corporation (INS), Predictive Technology Group, Inc. (PRED), Rockwell Medical, Inc. (RMTI), Sinclair Broadcast Group, Inc. (SBGI), ShockWave Medical, Inc. (SWAV), Taitron Components Incorporated (TAIT), Veracyte, Inc. (VCYT), Voyager Therapeutics, Inc. (VYGR), and Zynerba Pharmaceuticals, Inc. (ZYNE).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.